HighTide Therapeutics Inc

Direct answer

HighTide Therapeutics Inc is publicly traded on HKSE under the ticker 2511.HK.

HighTide Therapeutics, Inc. operates as an investment holding company focused on the entire lifecycle from discovery to commercialization of innovative, multi-faceted therapeutic solutions. These solutions are specifically engineered to tackle metabolic and digestive disorders where current treatments fall short. The company's flagship pharmaceutical candidate, HTD1801, functions as a gut-liver anti-inflammatory...

Can you invest in HighTide Therapeutics Inc?

Yes. HighTide Therapeutics Inc is publicly traded on HKSE under the ticker 2511.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for HighTide Therapeutics Inc

Detailed equity research is provided by MarketSnap.